4 FDA recalls mention Glyburide. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Glyburide.
Reason CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
Reason Labeling: Label Mixup: glyBURIDE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs: sulfaSALAzine, Tablet, 500 mg…
Reason Labeling: Label Mixup: glyBURIDE, Tablet, 1.25 mg may have potentially been mislabeled as one of the following drugs: CYPROHEPTADINE HCL, Tablet, 4…
Reason Labeling: Label Mixup: glyBURIDE MICRONIZED, Tablet, 3 mg may have potentially been mislabeled as the following drug: DIGOXIN, Tablet, 0.125 mg, NDC…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.